Yes, that is a picture of Dr. Alan Steere, one of the three doctors at Yale who discovered Lyme back in 1979.
So much has happened in the last three decades, but it took less than 10 years for researchers to
determine that Borrelia persisted after short treatments of antibiotics, in spite of the ongoing medical debate about chronic Lyme disease.
I have been promising a book for over a year now listing over 100 sources that show pervasiveness of Borrelia infection after antibiotic treatment. Unfortunately personal issues delayed my progress, however, the good news is that I now have more studies to add which are even more detailed and meaningful.
A sneak preview written by Dr. Keith Berndtson and published in Pub Med:
ABSTRACT:”Is chronic illness in patients with Lyme disease caused by persistent infection? Three decades of basic and clinical research have yet to produce a definitive answer to this question. This review describes known and suspected mechanisms by which spirochetes of the Borrelia genus evade host immune defenses and survive antibiotic challenge. Accumulating evidence indicates that Lyme disease spirochetes are adapted to persist in immune competent hosts, and that they are able to remain infective despite aggressive antibiotic challenge. Advancing understanding of the survival mechanisms of the Lyme disease spirochete carry noteworthy implications for ongoing research and clinical practice.”
From Conclusion: Well-established mechanisms for immune system evasion make a highly plausible case for Bb’s ability to establish an infection that could survive host immune defenses during early and late phases of dissemination. Video evidence reveals how quickly Bb can exit the vascular compartment and translocate into ECM tissues. Preliminary evidence suggests that Bb may participate in quorum sensing, biofilm-like behavior, and persister cell induction. Such mechanisms would help explain Bb’s ability to survive not just initial antibiotic therapy, but ongoing aggressive antibiotic therapy as well. Credible evidence supports the conclusion that LD can be a recalcitrant and chronic relapsing infection in animal hosts. While postinfectious immune pathology likely accounts for certain aspects of the morbidity seen in LD patients following standard antibiotic treatment such mechanisms were not the subject of this review.
Berndtson, K. (2013, April 23). Abstract. Retrieved December 7, 2014, from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636972/
I highly recommend you read the entire study as the research explores all the possible reasons for the chronic nature of Lyme disease.
Yet in spite of the steadily growing evidence of the ability of spirochetes to persist after antibiotic treatment, yet Dr. Alan Steere, the head of the IDSA and the reigning authority on Lyme disease at Harvard University and for most every infectious disease MD in the US states emphatically:
“There is no evidence that the Lyme bacteria are resistant to any of the antibiotics commonly used to treat the infection. In rare cases, additional therapy beyond the recommended doses may be used for brief periods of time (typically one month). However there is no evidence that additional treatment with any antibiotic results in improvement of slowly resolving symptoms.”
(See http://www.uptodate.com/contents/lyme-disease-treatment-beyond-the-basics )
I believe that demonstrates the most obscene lack of responsibility for the health and welfare of human beings world-wide and a gross abuse of power.